Marybeth Gasman of the Graduate School of Education comments on African-American graduation rates.
Penn in the News
Thomas Sugrue of the School of Arts and Sciences says taking a stand on high-profile cases is often used to bolster recognition of national organizations.
James English of the School of Arts and Sciences discusses the necessity of awards in society.
James English of the School of Arts and Sciences addresses the state of the literary world.
Paul Rozin of the School of Arts and Sciences says lunch in America is more a chore than a course.
Mark V. Pauly of Penn’s Wharton School says co-pays have their advantages for insurers.
R. Polk Wagner of the Law School is cited for his work on intellectual patents.
Jeremy Siegel of Penn’s Wharton School discusses the recent surge in the Dow.
Mitch Lazar of the School of Medicine comments on the relationship between diabetes and cardiovascular problems.
Peter Capelli of Penn’s Wharton School says IBM has led the way in quality of benefits and retirement.
Penn’s neighborhood-revitalization efforts are highlighted.
Kent Smetters of Penn’s Wharton School discusses the magnitude of President Bush’s budget proposals.
Michael Eric Dyson of the School of Arts and Sciences comments on the newly installed president of entertainment for Black Entertainment Television.
Michael Eric Dyson of the School of Arts and Sciences says Bill Cosby should not be held up as a sociological expert.
Arthur Caplan of the School of Medicine discusses the societal reactions to Dick Clark’s New Year’s Eve appearance.
David Rudovsky of the Law School says that future technology will provide the government with unlimited spying capabilities.
President Amy Gutmann says competition for admission does reflect educational quality.
John Kromer of the School of Arts and Sciences says Philadelphia’s new tax breaks make living in the city just as cheap as living in the suburbs.
Arthur Caplan of the School of Medicine says that tissue-reclamation companies, not hospitals, are at fault for bad donor tissue.
John P. O'Reardon of the School of Medicine says the anti-depression implant is a last hope for some sufferers.